076 - The New Move: Treating Tardive Dyskinesia

Published: April 3, 2018, 10 a.m.

b'

In this episode, we discuss two new agents (valbenazine and deutetrabenazine) -- the first of their kind to receive FDA approval to manage tardive dyskinesia most commonly associated with antipsychotic use.

'